TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked.
Comparing STEP 8 (JAMA, 2022) with SCALE (N Engl J Med, 2015) and finding the comparison harder than it looks.
Different populations, different durations, different endpoints defined slightly differently, and in one case a different estimand. People compare the headline percentages anyway, including me until recently.
Is there a defensible way to put these side by side, or is the honest answer that there is not and we should stop?